EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for CRNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -5.045
March 31, 2026 -5.133
December 31, 2025 -4.945
September 30, 2025 -4.534
June 30, 2025 -4.112
March 31, 2025 -3.817
December 31, 2024 -3.703
September 30, 2024 -3.718
June 30, 2024 -3.770
March 31, 2024 -3.772
December 31, 2023 -3.699
September 30, 2023 -3.640
June 30, 2023 -3.408
March 31, 2023 -3.275
December 31, 2022 -3.148
September 30, 2022 -2.993
June 30, 2022 -2.940
March 31, 2022 -2.838
December 31, 2021 -2.806
Date Value
September 30, 2021 -2.782
June 30, 2021 -2.612
March 31, 2021 -2.432
December 31, 2020 -2.448
September 30, 2020 -2.391
June 30, 2020 -2.430
March 31, 2020 -2.420
December 31, 2019 -2.085
September 30, 2019 -1.838
June 30, 2019 -1.621
March 31, 2019 -1.840
December 31, 2018 -1.694
September 30, 2018 -1.452
June 30, 2018 -1.172
March 31, 2018 -0.5075
December 31, 2017 -0.388
September 30, 2017 -0.2772
June 30, 2017 -0.1776
March 31, 2017 -0.109

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. 17.19
Johnson & Johnson 8.628
Eli Lilly & Co. 29.43
Pfizer Inc. 0.7552
Bristol Myers Squibb Co. 4.539